Advertisement
U.S. markets open in 7 hours 14 minutes

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
40.96-1.05 (-2.50%)
At close: 04:00PM EDT
40.73 -0.23 (-0.56%)
After hours: 06:09PM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,883
6,883
2,357
4,651
7,418
Operating Expense
148,925
148,925
109,453
73,799
56,990
Operating Income
-142,042
-142,042
-107,096
-69,148
-49,572
Other Income Expense
613
613
-5,229
-1,590
-11,375
Pretax Income
-141,429
-141,429
-112,325
-70,738
-60,947
Tax Provision
0
0
0
-227
-1,167
Net Income Common Stockholders
-141,429
-141,429
-112,325
-70,511
-59,780
Diluted NI Available to Com Stockholders
-141,429
-141,429
-112,325
-70,511
-59,780
Basic EPS
-1.64
-2.92
-2.40
-1.64
-2.02
Diluted EPS
-1.64
-2.92
-2.40
-1.64
-2.02
Basic Average Shares
42,870
48,449
46,888
42,870
29,640
Diluted Average Shares
42,870
48,449
46,888
42,870
29,640
Total Operating Income as Reported
-154,542
-154,542
-115,234
-71,243
-63,354
Total Expenses
148,925
148,925
109,453
73,799
56,990
Net Income from Continuing & Discontinued Operation
-141,429
-141,429
-112,325
-70,511
-59,780
Normalized Income
-142,042
-142,042
-107,096
-68,926
-48,623
EBIT
-142,042
-142,042
-107,096
-69,148
-49,572
EBITDA
-139,034
-139,034
-104,200
-66,080
-45,643
Reconciled Depreciation
3,008
3,008
2,896
3,068
3,929
Net Income from Continuing Operation Net Minority Interest
-141,429
-141,429
-112,325
-70,511
-59,780
Total Unusual Items Excluding Goodwill
613
613
-5,229
-1,590
-11,375
Total Unusual Items
613
613
-5,229
-1,590
-11,375
Normalized EBITDA
-139,647
-139,647
-98,971
-64,490
-34,268
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-5.1023
-217.806